← Browse by Condition
Medical Condition

pancreas disease

Total Trials
3
Recruiting Now
3
Trial Phases
Various

ClinicalMetric tracks all active clinical trials for pancreas disease sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — pancreas disease Clinical Trials

How many clinical trials are currently recruiting for pancreas disease?
ClinicalMetric currently tracks 3 actively recruiting clinical trials for pancreas disease, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 3. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for pancreas disease?
pancreas disease research spans multiple clinical trial phases. Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a pancreas disease clinical trial?
Eligibility criteria for pancreas disease trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Top Sponsors
Umeå University 1 trial
Asian Institute of Gastroenterology, India 1 trial
Stanford University 1 trial

Recruiting Clinical Trials

NCT05356039
Recruiting
Survival, Quality of Life and Resectability in Locally Advanced Pancreatic Cancer
Enrollment
300 pts
Location
Sweden
Sponsor
Umeå University
View Trial →
NCT07574970
Recruiting
A COMBINATION OF RECTAL INDOMETHACIN AND COLD WATER EXPOSURE OF THE AMPULLA AFTER ERCP IS SUPERIOR TO RECTAL INDOMETHACIN ALONE IN REDUCING THE INCIDENCE OF POST-ERCP PANCREATITIS -RCT
Enrollment
150 pts
Location
India
Sponsor
Asian Institute of Gastroenter...
View Trial →
NCT03260842
Recruiting
Bio-Repository of High Risk Cohorts for the Early Detection of Pancreas Cancer
Enrollment
500 pts
Location
United States
Sponsor
Stanford University
View Trial →

Related Conditions

pancreas cancer (1) pancreas neoplasm (1) pancreas adenocarcinoma (1) surgery (1) chemotherapy effect (1) quality of life (1) locally advanced pancreatic adenocarcinoma (1) borderline resectable pancreatic adenocarcinoma (1) pancreatic cyst (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology